1.
In-vitro characterisation of a novel antimicrobial agent, TNP-2092, against Helicobacter pylori clinical isolates. Swiss Med Wkly [Internet]. 2018 Jul. 24 [cited 2026 Feb. 1];148(2930):w14630. Available from: https://www.smw.ch/index.php/smw/article/view/2501